Active Ingredient History

NOW
  • Now
Dornase alfa is a highly purified solution of recombinant human deoxyribonuclease I (rhDNase), an enzyme which selectively cleaves DNA. Dornase alfa hydrolyzes the DNA present in sputum/mucus of cystic fibrosis patients and reduces viscosity in the lungs, promoting improved clearance of secretions. This protein therapeutic agent is produced in Chinese hamster ovary cells.   Wikipedia

More Chemistry
  • Mechanisms of Action:
  • Multi-specific: No
  • Black Box: No
  • Availability: Prescription Only
  • Delivery Methods: Parenteral
  • Pro Drug: No

Drug Pricing (per unit)

Australia

$24.7698

United States

$44.5308 - $679.1220
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

deanase | deoxyribonuclease | deoxyribonuclease (human clone 18-1 protein moiety) | desoxyribonuclease | dornase | dornase alfa | dornase alfa (desoxyribonuclease) | dornase alfa (genetical recombination) | dornase alfa, recombinant | dornase alpha | human dnase-1 | pulmozyme | recombinant deoxyribonuclease | recombinant deoxyribonuclease (dnase) | recombinant human deoxyribonuclease i | recombinant human dnase | rhdnase

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue